November 24, 2020
Courtney Lindsay
Tim Buchmiller
Office of Life Sciences
Division of Corporation Finance
U.S. Securities and Exchange Commission
Washington, D.C. 20549
Re: Global Cancer Technology, Inc.
Regulation A Offering Statement on Form 1-A
CIK No. 0001743261
Dear Mr. Lindsay and Mr. Buchmiller:
Global Cancer Technology, Inc. has today filed the above-referenced amended Regulation A Offering Statement on Form 1-A/A (File No. 024-11314) for the sole purpose of providing an updated auditor consent under Rule 252(f)(iii).
Please feel free to contact me if further information is required for this filing.
Sincerely, | |
/s/ Ronald N. Vance | |
Ronald N. Vance, Partner |